Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2026-02-24 @ 6:45 PM
Study NCT ID:
NCT03942120
Status:
COMPLETED
Last Update Posted:
2025-04-27
First Post:
2019-05-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Post-Marketing Surveillance for Crohn's Disease Participants Treated With Stelara (Ustekinumab)
Sponsor:
Janssen Korea, Ltd., Korea
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-08
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-14
Completion Date Type:
ACTUAL
First Submit Date:
2019-05-07
First Submit QC Date:
None
Study First Post Date:
2019-05-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-25
Last Update Post Date:
2025-04-27
Last Update Post Date Type:
ACTUAL